CRY1 and atherosclerosis: CRY1 mRNA expression is significantly lower in patients with atherosclerosis, while augmented CRY1 expression reverses the atherosclerotic process by the Toll-like receptor (TLR)/nuclear factor kappa-B (NF-κB) pathway [9, 108].